CHMP takes positive stance at October meeting
This article was originally published in Scrip
Executive Summary
The European Union'sCommittee for Medicinal Products for Human Use (CHMP) was clearly in a positive frame of mind as it recommended approval for all the treatments it was assessing at this month's meeting. The committee issued positive opinions on an AstraZeneca influenza vaccine, three generics and adopted indication extensions for three already authorised medicines.